Advertisement
Letter to the Editor| Volume 404, P157-158, September 15, 2019

Download started.

Ok

Response to “Letter to the editors in regard to the article ‘Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis’”

      We would like to thank Dr. Pike-Lee for the inquiry regarding our study [
      • Kanai T.
      • Uzawa A.
      • Kawaguchi N.
      • et al.
      Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.
      ]. We would like to explain the factors included in our score, especially early-onset myasthenia gravis (EOMG) or thymoma-associated myasthenia gravis (TAMG) and the incorrect number of patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kanai T.
        • Uzawa A.
        • Kawaguchi N.
        • et al.
        Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.
        J. Neurol. Sci. 2019; 396: 8-11
        • Murai H.
        • Masuda M.
        • Utsugisawa K.
        • et al.
        Clinical features and treatment status of adult myasthenia gravis in Japan.
        Clin Exp Neuroimmunol. 2014; 5: 84-91